This amendment adds language requiring the Pharmacy and Therapeutics Committee to ensure that any non opioid drug approved by the federal Food and Drug Administration shall be considered for safety and clinical efficacy and cost effectiveness pursuant to requirements set forth in the Virginia Administrative Code. Language is also added requiring the Department of Medical Assistance Services to conduct a fiscal impact review on recommendations from the Pharmacy and Therapeutics Committee that would result in changes to the program's Common Core Formulary. In addition, it requires that the Pharmacy and Therapeutics Committee include as part of its membership one physician or pharmacist from each contracted managed care organization.